Financials

Discussions Technicals Seasonals

EBIT of MEDIPLANTEX NATIONAL PHARMACEUTICAL

Annual data

2011

2018

2019

2020

2021

2022

2023

2024

TTM

‪0.00‬

‪‪7.00 B‬‬

‪‪14.00 B‬‬

‪‪21.00 B‬‬

‪‪28.00 B‬‬

Period

Value

Change

Change %

TTM

‪‪22.69 B‬‬

+‪‪575.35 M‬‬

+‪2.60‬%

2024

‪‪22.11 B‬‬

+‪‪7.93 B‬‬

+‪55.94‬%

2023

‪‪14.18 B‬‬

+‪‪5.10 B‬‬

+‪56.08‬%

2022

‪‪9.09 B‬‬

+‪‪938.13 M‬‬

+‪11.51‬%

2021

‪‪8.15 B‬‬

‪‪−19.07 B‬‬

‪−70.07‬%

2020

‪‪27.22 B‬‬

‪‪−23.81 B‬‬

‪−46.66‬%

2019

2018

2011

Quarterly data

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪0.00‬

‪‪2.00 B‬‬

‪‪4.00 B‬‬

‪‪6.00 B‬‬

‪‪8.00 B‬‬

Period

Value

Change

Change %

Q4 '24

‪‪4.72 B‬‬

‪‪−372.50 M‬‬

‪−7.32‬%

Q3 '24

‪‪5.09 B‬‬

‪‪−1.74 B‬‬

‪−25.43‬%

Q2 '24

‪‪6.83 B‬‬

+‪‪780.55 M‬‬

+‪12.91‬%

Q1 '24

‪‪6.05 B‬‬

+‪‪1.16 B‬‬

+‪23.70‬%

Q4 '23

‪‪4.89 B‬‬

+‪‪566.94 M‬‬

+‪13.12‬%

Q3 '23

‪‪4.32 B‬‬

+‪‪1.76 B‬‬

+‪68.40‬%

Q2 '23

‪‪2.57 B‬‬

+‪‪216.99 M‬‬

+‪9.23‬%

Q1 '23

‪‪2.35 B‬‬

+‪‪412.17 M‬‬

+‪21.27‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20